相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Osteopontin is a prognostic biomarker in non-small cell lung cancer
Ane Kongsgaard Rud et al.
BMC CANCER (2013)
Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration
Zsuzsa Rakosy et al.
PLOS ONE (2013)
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response
J. W. Thoms et al.
BRITISH JOURNAL OF CANCER (2012)
Current management and novel agents for malignant melanoma
Byung Lee et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Osteopontin expression in plasma of melanoma patients and in melanocytic tumours
T. Maier et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers
Dong-Xing Cao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Plasma Markers for Identifying Patients with Metastatic Melanoma
Harriet M. Kluger et al.
CLINICAL CANCER RESEARCH (2011)
Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma
Nadia A. Atai et al.
IMMUNOLOGY (2011)
Malignant Melanoma in the Elderly: Different Regional Disease and Poorer Prognosis
James B. Macdonald et al.
JOURNAL OF CANCER (2011)
Worldwide Increasing Incidences of Cutaneous Malignant Melanoma
Dianne E. Godar
JOURNAL OF SKIN CANCER (2011)
Melanoma sentinel node biopsy and prediction models for relapse and overall survival
A. Mitra et al.
BRITISH JOURNAL OF CANCER (2010)
Osteopontin is a marker for cancer aggressiveness and patient survival
G. F. Weber et al.
BRITISH JOURNAL OF CANCER (2010)
Melanoma staging: Facts and controversies
Andrea Forschner et al.
CLINICS IN DERMATOLOGY (2010)
Osteopontin: An Effector and an Effect of Tumor Metastasis
L. A. Shevde et al.
CURRENT MOLECULAR MEDICINE (2010)
Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival
Caroline Conway et al.
CLINICAL CANCER RESEARCH (2009)
Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology
Franziska Buback et al.
EXPERIMENTAL DERMATOLOGY (2009)
Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue
Stephen S. Koh et al.
MODERN PATHOLOGY (2009)
The Functional-443T/C Osteopontin Promoter Polymorphism Influences Osteopontin Gene Expression in Melanoma Cells via Binding of c-Myb Transcription Factor
Julia Schultz et al.
MOLECULAR CARCINOGENESIS (2009)
Determination and validation of off-target activities of anti-CD44 variant 6 antibodies using protein biochips and tissue microarrays
Angelika Lueking et al.
BIOTECHNIQUES (2008)
Osteopontin: Role in immune regulation and stress responses
Kathryn X. Wang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Osteopontin as a molecular prognostic marker for melanoma
Javier Rangel et al.
CANCER (2008)
Osteopontin: regulation in tumor metastasis
Philip Y. Wai et al.
CANCER AND METASTASIS REVIEWS (2008)
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
Akeila Bellahcene et al.
NATURE REVIEWS CANCER (2008)
Osteopontin overexpression in breast cancer: Knowledge gained and possible implications for clinical management
Alan B. Tuck et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Control of osteopontin signaling and function by post-translational phosphorylation and protein folding
Christian C. Kazanecki et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
The role of osteopontin in tumor progression and metastasis in breast cancer
Ligia R. Rodrigues et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues
Jochen Jaeger et al.
CLINICAL CANCER RESEARCH (2007)
The regulation and role of osteopontin in malignant transformation and cancer
Mohamed K. El-Tanani et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN
Leisl Packer et al.
CARCINOGENESIS (2006)
Malignant melanoma: genetics and therapeutics in the genomic era
Lynda Chin et al.
GENES & DEVELOPMENT (2006)
Papilloma development is delayed in osteopontin-null mice: Implicating an antiapoptosis role for osteopontin
Yu-Hua Hsieh et al.
CANCER RESEARCH (2006)
Osteopontin: role in cell signaling and cancer progression
H Rangaswami et al.
TRENDS IN CELL BIOLOGY (2006)
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas
AP Smith et al.
CANCER BIOLOGY & THERAPY (2005)
Osteopontin:: it's role in regulation of cell motility and nuclear factor κB-mediated urokinase type plasminogen activator expression
R Das et al.
IUBMB LIFE (2005)
Osteopontin expression correlates with melanoma invasion
YW Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
The gene expression signatures of melanoma progression
C Haqq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The activation of Akt/PKB signaling pathway and cell survival
G Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Role of osteopontin in tumour progression
SR Rittling et al.
BRITISH JOURNAL OF CANCER (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
P700: the primary electron donor of photosystem I
AN Webber et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2001)
Osteopontin
J Sodek et al.
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE (2000)
分享论文
